Revista: | Brazilian Journal of Pharmaceutical Sciences |
Base de datos: | PERIÓDICA |
Número de sistema: | 000451687 |
ISSN: | 1984-8250 |
Autores: | Cardona, Wilson1 Robledo, Sara Maria2 Prieto, Laura Juliana1 Yépes, Andrés Felipe1 |
Instituciones: | 1Universidad de Antioquia, Facultad de Ciencias Exactas y Naturales, Medellín, Antioquia. Colombia 2Universidad de Antioquia, Escuela de Medicina, Medellín, Antioquia. Colombia |
Año: | 2022 |
Volumen: | 58 |
País: | Brasil |
Idioma: | Inglés |
Tipo de documento: | Artículo |
Enfoque: | Experimental, aplicado |
Resumen en inglés | In order to overcome the challenges of discovering new antiprotozoal drugs, we synthesized a new class of hybrids based on S-allylCysteine Ester/Caffeic Acid Amide and evaluated four of them against Trypanosoma cruzi and Plasmodium falciparum. Hybrid 6 exhibited good activity on T. cruzi with an EC50 value of 5.45 µM, whereas hybrid 3 was active over P. falciparum with an EC50 of 18.08 µM. All hybrids displayed a good selectivity index on P. falciparum. Molecular docking computations indicated that several hybrids have good binding affinities towards the protozoa related enzymes (Cruzipain or Falcipain-2) when compared against current inhibitors. In silico studies showed that conjugates 1-3 and 6 fulfilled optimal ADME characteristics, suggesting them as safe alternatives for oral treatment of protozoal infections |
Disciplinas: | Química |
Palabras clave: | Química farmacéutica, Enfermedad de Chagas, Paludismo, S-alil cisteína, Acido cafeico |
Keyword: | Medicinal chemistry, S-allyl cysteine, Caffeic acid, Chagas disease, Malaria |
Texto completo: | Texto completo (Ver HTML) Texto completo (Ver PDF) |